Compositions and methods including a recombinant human MAB that promotes CNS remyelination

Details for Australian Patent Application No. 2004247021 (hide)

Owner Mayo Foundation for Medical Education & Research Acorda Therapeutics

Inventors Rodriguez, Moses; Chojnicki, Eric; Bieber, Allan J.; Gruskin, Elliot A.; Warrington, Arthur E.

Agent Madderns

Pub. Number AU-A-2004247021

PCT Pub. Number WO2004/110355

Priority 60/471,235 16.05.03 US

Filing date 17 May 2004

Wipo publication date 23 December 2004

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/110355 Priority application(s): WO2004/110355

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247023-Heterocyclic compounds and uses thereof

2004247018-Novel immunomodulating peptide